Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Technology
Share your love
Atsena Publishes 12-Month Data on ATSN-101 for LCA1
Atsena Therapeutics announced that 12-month safety and efficacy data from its Phase I/II trial of ATSN-101, a gene therapy for Leber congenital amaurosis caused by GUCY2D mutations (LCA1), were published in The Lancet. ATSN-101 showed durable improvements in vision at…
Alcon to Unveil Updated MARLO App at SECO 2024
Alcon announced significant updates to its MARLO App, set to be unveiled at the SECO International meeting in Atlanta. This advanced version of the app, featuring new functionalities, aims to further elevate the patient experience. Patients can now conveniently access…
Shamir Launches Spark 4W Eye Measurement Tech
Shamir has launched the Spark 4W, a digital electro-optic measurement system set to revolutionize eye care practices. Leveraging 3D stereo vision technology and artificial intelligence (AI), the Spark 4W aims to streamline and enhance the process of obtaining precise pupillary…
FDA Clears Eyenuk’s Additional Camera for DR Detection
Eyenuk has received FDA clearance to utilize the Topcon NW400 retinal camera with its EyeArt AI system for automated detection of diabetic retinopathy (DR). This clearance complements the system’s existing clearance for usage with Canon CR-2 AF and Canon CR-2…
Peters Anomaly: Causes, Symptoms and Management
What Is Peters Anomaly? Peters anomaly is a rare congenital ocular condition primarily affecting the anterior segment of the eye. At its core, it’s characterized by the abnormal development of the cornea’s central layers and potential adhesions between the cornea…
EVMANN Takes Two Innovative Companies Under its Umbrella
AMSTERDAM, Oct. 5, 2021 /PRNewswire/ — Within framework of global growth strategy implemented in early 2021, VSY Biotechnology GmbH-Germany and Alsanza Medizintechnik und Pharma GmbH-Germany companies which manufacture and sell their innovative products in ophthalmology and orthopedy fields over 90 countries and 6 continents have decided to…
All About Phacoemulsification Procedure | OBN
The phacoemulsification procedure has transformed cataract surgery, offering a less invasive and more efficient method for cataract removal. This advanced surgical technique uses ultrasonic vibrations to emulsify the cloudy lens, which is then aspirated out and replaced with an artificial…
Brim Biotech’s Clinical Trial for DED Kicks Off
BRIM Biotechnology has initiated the Phase 3 clinical trial of BRM421 for the treatment of Dry Eye Disease (DED) and enrolled the first patient in the trial. This multicenter, double-blind, randomized, vehicle-controlled trial will enroll over 700 patients with moderate…
The Biggest Challenges in Ophthalmology Today
A recent survey conducted by OBN on LinkedIn asked participants to identify the most pressing challenge facing the ophthalmology field today. The poll revealed that nearly half of the respondents believe patient access to care is the primary issue, followed…
Therapeutic Contact Lenses Market to Grow Significantly
A recent report by Future Market Insights has made some exciting predictions about the therapeutic contact lenses market. The report states that the market is set to experience significant growth in the next decade, rising from an estimated USD 12,595.3…